Cholesterol-stabilized membrane-active nanopores with anticancer activities

被引:0
|
作者
Jie Shen
Yongting Gu
Lingjie Ke
Qiuping Zhang
Yin Cao
Yuchao Lin
Zhen Wu
Caisheng Wu
Yuguang Mu
Yun-Long Wu
Changliang Ren
Huaqiang Zeng
机构
[1] Xiamen University,Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences
[2] Fuzhou University,College of Chemistry
[3] Nanyang Technological University,School of Biological Sciences
[4] Shenzhen Research Institute of Xiamen University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol-enhanced pore formation is one evolutionary means cholesterol-free bacterial cells utilize to specifically target cholesterol-rich eukaryotic cells, thus escaping the toxicity these membrane-lytic pores might have brought onto themselves. Here, we present a class of artificial cholesterol-dependent nanopores, manifesting nanopore formation sensitivity, up-regulated by cholesterol of up to 50 mol% (relative to the lipid molecules). The high modularity in the amphiphilic molecular backbone enables a facile tuning of pore size and consequently channel activity. Possessing a nano-sized cavity of ~ 1.6 nm in diameter, our most active channel Ch-C1 can transport nanometer-sized molecules as large as 5(6)-carboxyfluorescein and display potent anticancer activity (IC50 = 3.8 µM) toward human hepatocellular carcinomas, with high selectivity index values of 12.5 and >130 against normal human liver and kidney cells, respectively.
引用
收藏
相关论文
共 50 条
  • [1] Cholesterol-stabilized membrane-active nanopores with anticancer activities
    Shen, Jie
    Gu, Yongting
    Ke, Lingjie
    Zhang, Qiuping
    Cao, Yin
    Lin, Yuchao
    Wu, Zhen
    Wu, Caisheng
    Mu, Yuguang
    Wu, Yun-Long
    Ren, Changliang
    Zeng, Huaqiang
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] ALKYLPHOSPHOCHOLINES - A NEW CLASS OF MEMBRANE-ACTIVE ANTICANCER AGENTS
    HILGARD, P
    KLENNER, T
    STEKAR, J
    UNGER, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (02) : 90 - 95
  • [3] Membrane-Active Anticancer Peptides: Functional Association Modes with Lipid Bilayers
    Queme-Pena, Mayra
    Juhasz, Tunde
    Kohut, Gergely
    Ricci, Maria
    Singh, Priyanka
    Szigyarto, Imola Cs
    Beke-Somfai, Tamas
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [4] Association of annexin 2 with recycling endosomes requires either calcium- or cholesterol-stabilized membrane domains
    Zeuschner, D
    Stoorvogel, W
    Gerke, V
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2001, 80 (08) : 499 - 507
  • [5] Membrane-active aminophosphonates
    Dziamska, A
    Sarapuk, J
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2002, 7 (02) : 282 - 282
  • [6] Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: The case of killerFLIP
    Vaezi, Zahra
    Bortolotti, Annalisa
    Luca, Vincenzo
    Perilli, Giulia
    Mangoni, Maria Luisa
    Khosravi-Far, Roya
    Bobone, Sara
    Stella, Lorenzo
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2020, 1862 (02):
  • [7] Dual Antimicrobial and Anticancer Activity of Membrane-Active Peptide BP52
    Phuong, Hai Bui Thi
    Ngan, Hoa Doan
    Thi, Hue Pham
    Thanh, Binh Nguyen Thi
    Dang, Tien T.
    Ho, Thao N. T.
    Thanh, Tung Truong
    Hong, Minh Nguyen
    Xuan, Huy Luong
    PROTEIN JOURNAL, 2024, 43 (05): : 1025 - 1034
  • [8] MEMBRANE-ACTIVE ANTIBACTERIAL COMPOUNDS
    HAMILTON, WA
    BIOCHEMICAL JOURNAL, 1970, 118 (03) : P46 - &
  • [9] Membrane-active agents - II
    Tripathi, Kishu
    Kulshreshtha, Shobha
    ORIENTAL JOURNAL OF CHEMISTRY, 2008, 24 (02) : 623 - 628
  • [10] Viral Size Modulates Sendai Virus Binding to Cholesterol-Stabilized Receptor Nanoclusters
    Lam, Amy
    Yuan, Daniel S.
    Ahmed, Samir H.
    Rawle, Robert J.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2022, 126 (36): : 6802 - 6810